Skip to content
← All findings
AS-2026-0006AS STATEDLANE A

On two-dose measles vaccine efficacy

The stated 97 percent efficacy figure for the two-dose MMR schedule was substantiated against CDC and peer-reviewed sources.

Subject
A public-health educator
Handle
@doc.reyes
Platform
Instagram
Topic
Health
Published

In a short explainer, the subject stated that two doses of the measles vaccine are about 97 percent effective at preventing measles. The claim drew a large and contested reply thread. It was accepted into Lane A under a matched pledge.

"Two doses of MMR are about 97% effective against measles. One dose is about 93%."

The figure is specific, falsifiable, and central to a public-health decision many viewers make. Materiality and reach were both clear.

What the record shows

The 97 percent figure for the two-dose schedule, and 93 percent for a single dose, are the standing estimates published by the CDC and supported by the peer-reviewed effectiveness literature the agency cites. These are automatically qualifying sources under the Evidence Standard.

The subject provided the CDC's vaccine effectiveness page and two of the underlying studies on request. The numbers were quoted as central estimates, not as guarantees — a distinction the original post preserved.

Finding

The claim was substantiated at the precision stated. The subject represented the range honestly, including the lower single-dose figure, and did not overstate certainty.

The record stands as presented.

Outcome

AS STATED

The claim was substantiated with qualifying sources. The record stands as the subject presented it.